SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : RNAi

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (24)6/3/2003 12:43:08 AM
From: BulbaMan  Read Replies (1) of 671
 
From Ribozyme (Sirna) SCHEDULE 14A INFORMATION (filed with SEC 2/24/03)
LOCK-UP AGREEMENTS.
We have agreed to enter into agreements with each of our officers, continuing directors, and certain key employees, so that those stockholders will not sell or otherwise transfer or dispose of their ownership interests in RPI for a period of 180 days after the consummation of the Private Placement, other than for transfers to certain permitted transferees or in private resales. The investors also have agreed to enter into similar lock-up agreements. However, these agreements may be waived at any time by our board of directors, which, following consummation of the Private Placement, will have a majority of the directors designated by certain of the investors.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext